← Eichor
Condition: Withdrawal Symptoms Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Withdrawal Symptoms

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Phase 3 · 20 location(s) · Neurocrine Biosciences · NCT07227818Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder
NA · 1 location(s) · Payel Roy · NCT07079826Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Phase 3 · 51 location(s) · Axsome Therapeutics, Inc. · NCT07398417Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Phase 3 · 6 location(s) · Emory University · NCT05834478Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 2/Phase 3 · 118 location(s) · Janssen Research & Development, LLC · NCT05327114Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal
Phase 2 · 1 location(s) · University of Calgary · NCT04939623Cannabis, Linked Emotions, and Adolescent Risk Study
NA · 1 location(s) · Massachusetts General Hospital · NCT06576076Effect of Chest Tube Withdrawal on Patients' Anxiety Levels After Thoracic Surgery
Phase N/A · 1 location(s) · Ankara Ataturk Sanatorium Training and Research Hospital · NCT06531928Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain
NA · 1 location(s) · The University of Texas Medical Branch, Galveston · NCT05555485Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
Phase 4 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05461820Prazosin for Alcohol Use Disorder With Withdrawal Symptoms
Phase 2 · 2 location(s) · Yale University · NCT04793685The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments
NA · 4 location(s) · Ottawa Heart Institute Research Corporation · NCT04163081Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression
Phase 4 · 1 location(s) · University of North Carolina, Chapel Hill · NCT06610305Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
Phase 3 · 21 location(s) · PleoPharma, Inc. · NCT07644052Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pai
NA · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06290661Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Phase 3 · 40 location(s) · Axsome Therapeutics, Inc. · NCT07484217ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain
Phase 1/Phase 2 · 1 location(s) · Medical University of South Carolina · NCT06442566Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Sem
Phase 3 · 1 location(s) · Mount Sinai Hospital, Canada · NCT07294950Cerebral and Cognitive Impact of Professional Soccer Practice
NA · 1 location(s) · University Hospital, Strasbourg, France · NCT04903015Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients
NA · 1 location(s) · Chiao-Chiao Liao · NCT07466875Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder
Phase N/A · 2 location(s) · Spark Biomedical, Inc. · NCT06487533Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms
NA · 1 location(s) · Nu Eyne Co., Ltd. · NCT07079215Neural Correlates and Behavioral Impact of Withdrawal-induced Hyperalgesia Among People Who Smoke With and Without Chron
NA · 1 location(s) · Duke University · NCT06983678Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool
NA · 1 location(s) · University Hospital, Montpellier · NCT06618755
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.